(Reuters) – Pfizer Inc and BioNTech said on Wednesday they had signed a $3.2 billion deal with the U.S. government for 105 million doses of their COVID-19 vaccine for delivery as soon as late summer this year. The deal also includes an Omicron-adapted vaccine, pending regulatory clearance, Pfizer …

Source link

By admin

Leave a Reply

Your email address will not be published. Required fields are marked *